NSCLC (NON-SMALL CELL LUNG CARCINOMA)
Clinical trials for NSCLC (NON-SMALL CELL LUNG CARCINOMA) explained in plain language.
Never miss a new study
Get alerted when new NSCLC (NON-SMALL CELL LUNG CARCINOMA) trials appear
Sign up with your email to follow new studies for NSCLC (NON-SMALL CELL LUNG CARCINOMA), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New combo targets hard-to-treat lung cancer with precision
Disease control Not yet recruitingThis study tests whether a drug called firmonertinib, taken as a pill, combined with targeted radiation can help people with a certain type of stage III lung cancer that cannot be removed by surgery. The cancer must have a specific gene change (EGFR uncommon mutation). About 15 a…
Matched conditions: NSCLC (NON-SMALL CELL LUNG CARCINOMA)
Phase: PHASE2 • Sponsor: Hunan Cancer Hospital • Aim: Disease control
Last updated May 22, 2026 14:02 UTC
-
New hope for lung cancer patients with brain lining spread: drug combo trial launches
Disease control Not yet recruitingThis study tests a combination of two treatments for people with a specific type of lung cancer (NSCLC with EGFR mutation) whose cancer has spread to the lining of the brain or spinal cord (leptomeningeal metastasis) after prior targeted therapy. The treatment combines an oral dr…
Matched conditions: NSCLC (NON-SMALL CELL LUNG CARCINOMA)
Phase: PHASE2 • Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences • Aim: Disease control
Last updated May 19, 2026 11:47 UTC